Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Germany Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20035
20042
20052
20077
20087
20096
201010
20118
20123
20139
201413
201512
20168
20177
20185
20197
20208
20218
20226
20238
20241
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Terminated32
Active, not recruiting14
Recruiting13
Unknown status12
Withdrawn3
Not yet recruiting1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals16
Celgene14
European Organisation for Research and Treatment of Cancer - EORTC9
Technische Universität Dresden6
Bristol-Myers Squibb5
Heinrich-Heine University, Duesseldorf5
Kiadis Pharma5
AbbVie4
Takeda4
Traws Pharma, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes157
Leukemia, Myeloid, Acute57
Leukemia, Myelomonocytic, Chronic29
Anemia22
Leukemia15
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Anemia, Refractory, with Excess of Blasts12
Myeloproliferative Disorders10
Hematologic Neoplasms9
Multiple Myeloma7

Trials

Showing 26 to 50 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.